Index by author

March 01, 1992; Volume 59,Issue 2

  1. Flanagan, Richard A.

    1. Annular pancreas and intermittent duodenal obstruction in an alcoholic adult
      James C. Sperrazza, BS, Richard A. Flanagan, MD and Mark R. Katlic, MD
      Cleveland Clinic Journal of Medicine March 1992, 59 (2) 208-210;

      This congenital condition, in which pancreatic tissue encircles the middle portion of the duodenum, may not cause symptoms until adulthood, as was the case in this 49-year-old man.

  2. Gardner, Laurence B.

    1. Lactic Acidosis: Causes and Treatments
      Laurence B. Gardner, MD
      Cleveland Clinic Journal of Medicine March 1992, 59 (2) 141-142;

  3. Glicklich, Mark

    1. Mental status changes in an immunocompromised patient
      Cathryn Powers, MD, Mark Glicklich, MD and Kathleen Gleason Beavis, MD
      Cleveland Clinic Journal of Medicine March 1992, 59 (2) 211-215;

      A young patient with Burkitt’s lymphoma and acute lymphoblastic leukemia was found unarousable following 3 days of forgetfulness and expressive nominal aphasia.

  4. Katlic, Mark R.

    1. Annular pancreas and intermittent duodenal obstruction in an alcoholic adult
      James C. Sperrazza, BS, Richard A. Flanagan, MD and Mark R. Katlic, MD
      Cleveland Clinic Journal of Medicine March 1992, 59 (2) 208-210;

      This congenital condition, in which pancreatic tissue encircles the middle portion of the duodenum, may not cause symptoms until adulthood, as was the case in this 49-year-old man.

  5. Lerner, Phillip I.

    1. Endocarditis prophylaxis: the new guidelines
      Phillip I. Lerner, MD
      Cleveland Clinic Journal of Medicine March 1992, 59 (2) 216-218;

  6. Lund-johansen, Per

    1. The hemodynamic effects of adrenergic blocking agents
      Alan Bakst, PharmD and Per Lund-Johansen
      Cleveland Clinic Journal of Medicine March 1992, 59 (2) 193-200;

      Alpha-1 blockers may suit patients with active life-styles, peripheral vascular disorders, or high blood-cholesterol levels, while beta blockers are useful in tachycardia, palpitations, or angina pectoris. An overview of the pharmacologic qualities and numerous clinical applications of these agents.

  7. Maloney, James D.

    1. Indications for electrophysiologic study in patients with ventricular arrhythmias
      Sergio L. Pinski, MD and James D. Maloney, MD
      Cleveland Clinic Journal of Medicine March 1992, 59 (2) 175-185;

      An analysis of current guidelines for the use of electrophysiologic study, and a look at practical applications.

    2. Survivors of sudden cardiac death: a rational approach to evaluation and therapy of patients surviving ventricular fibrillation
      Arthur J. Rabinowitz, MD and James D. Maloney, MD
      Cleveland Clinic Journal of Medicine March 1992, 59 (2) 166-172;

      A strategy for identifying underlying disease, stratifying the risk of recurrence, and formulating specific therapy in these patients, at high risk for life-threatening ventricular tachyarrhythmias.

  8. Mcalister, Hugh

    1. Catheter ablation for recurrent ventricular tachycardia
      Ronald McCowan, MD, Bruce L. Wilkoff, MD, Hugh McAlister, MB, ChB and Tony W. Simmons, MD
      Cleveland Clinic Journal of Medicine March 1992, 59 (2) 203-207;

      Successful use of this procedure is described in a 78-yearold man with drug-refractory ventricular tachycardia who had both an implantable cardioverter-defibrillator and an antitachycardia pacemaker.

  9. Mccowan, Ronald

    1. Catheter ablation for recurrent ventricular tachycardia
      Ronald McCowan, MD, Bruce L. Wilkoff, MD, Hugh McAlister, MB, ChB and Tony W. Simmons, MD
      Cleveland Clinic Journal of Medicine March 1992, 59 (2) 203-207;

      Successful use of this procedure is described in a 78-yearold man with drug-refractory ventricular tachycardia who had both an implantable cardioverter-defibrillator and an antitachycardia pacemaker.

  10. Meeker, David P.

    1. Sleep in the patient with lung disease
      David P. Meeker, MD
      Cleveland Clinic Journal of Medicine March 1992, 59 (2) 157-165;

      How to recognize and manage the ill effects that sleep-related respiratory changes can have on underlying lung disease, including COPD, asthma, and interstitial lung disease.

« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue